Retatrutide vs Tirzepatide Retatrutide 20mg (R&D Only) is typically explored for broader multi-receptor activity Tirzepatide 20mg (R&D Only) is often used in dual-pathway receptor studies Comparative models help identify differences in signalling behaviour and metabolic response 20mg vs 40mg Options 20mg variants are suitable for baseline or controlled studies 40mg variants (such as Retatrutide 40mg) allow extended research and higher-range testing Recovery & Support Compounds BPC-157 & TB-500 40mg (R&D Only) are commonly explored in recovery-focused research models NAD+ 1,000mg is frequently integrated for cellular and mitochondrial studies This structured comparison approach enables researchers to build more comprehensive experimental frameworks across multiple pathways
The underlying drug in Mounjaro is a dual GIP and GLP-1 receptor agonist known as tirzepatide
Monitoring for gallbladder symptoms during treatment is advisable
I now take a tablet for anxiety, plus I take my bipolar meds, diabetes needles, metformin, asthma meds, and cholesterol medication
Lancet 394(10208):15191529 Lincoff AM, Brown-Frandsen K, Colhoun HM et al (2023) Semaglutide and cardiovascular outcomes in obesity without diabetes
Visceral fat is known to produce inflammatory cytokines at higher levels, so as GLP 1s reduce this fat, the inflammatory load on the body decreases